ID23377A - Senyawa-senyawa diamina siklik dan obat-obatan yang mengandung senyawa tersebut - Google Patents
Senyawa-senyawa diamina siklik dan obat-obatan yang mengandung senyawa tersebutInfo
- Publication number
- ID23377A ID23377A IDW991669A ID991669A ID23377A ID 23377 A ID23377 A ID 23377A ID W991669 A IDW991669 A ID W991669A ID 991669 A ID991669 A ID 991669A ID 23377 A ID23377 A ID 23377A
- Authority
- ID
- Indonesia
- Prior art keywords
- optionally substituted
- lower alkyl
- alkyl group
- integer
- compound
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 abstract 3
- 125000003107 substituted aryl group Chemical group 0.000 abstract 3
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 abstract 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 2
- -1 cyclic diamine compounds Chemical class 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 abstract 2
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- 125000004434 sulfur atom Chemical group 0.000 abstract 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 abstract 1
- 102000001494 Sterol O-Acyltransferase Human genes 0.000 abstract 1
- 108010054082 Sterol O-acyltransferase Proteins 0.000 abstract 1
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000005516 coenzyme A Substances 0.000 abstract 1
- 229940093530 coenzyme a Drugs 0.000 abstract 1
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 abstract 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 150000003457 sulfones Chemical class 0.000 abstract 1
- 150000003462 sulfoxides Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/70—Sulfur atoms
- C07D277/74—Sulfur atoms substituted by carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14989297 | 1997-05-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID23377A true ID23377A (id) | 2000-04-20 |
Family
ID=15484915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW991669A ID23377A (id) | 1997-05-26 | 1998-05-26 | Senyawa-senyawa diamina siklik dan obat-obatan yang mengandung senyawa tersebut |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0987254B1 (id) |
| JP (1) | JP3614865B2 (id) |
| KR (1) | KR100549804B1 (id) |
| CN (1) | CN1118457C (id) |
| AT (1) | ATE285402T1 (id) |
| AU (1) | AU728151B2 (id) |
| CA (1) | CA2290744C (id) |
| CZ (1) | CZ297451B6 (id) |
| DE (1) | DE69828276T2 (id) |
| ES (1) | ES2235328T3 (id) |
| HU (1) | HUP0002294A3 (id) |
| ID (1) | ID23377A (id) |
| NO (1) | NO315045B1 (id) |
| NZ (1) | NZ501156A (id) |
| PT (1) | PT987254E (id) |
| RU (1) | RU2207341C2 (id) |
| SK (1) | SK284891B6 (id) |
| TW (1) | TW589308B (id) |
| WO (1) | WO1998054153A1 (id) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6300500B1 (en) | 1998-02-25 | 2001-10-09 | Sumitomo Pharmaceuticals Company, Limited | Preparation of pyridone derivatives using phthalimido containing starting material |
| US6452008B2 (en) | 1998-02-25 | 2002-09-17 | Sumitomo Pharmaceuticals Company, Limited | Pyridone derivatives and process for preparing the same |
| CA2377226C (en) * | 1999-06-28 | 2009-01-27 | Kozo Aoki | Benzimidazole compounds and medicaments comprising the same |
| US6593323B1 (en) | 1999-06-30 | 2003-07-15 | Fuji Photo Film Co., Ltd. | Benzimidazole compounds and drugs containing the same |
| ATE262522T1 (de) | 1999-07-07 | 2004-04-15 | Fuji Photo Film Co Ltd | Benzimidazolverbindungen |
| JP4242765B2 (ja) * | 2001-08-22 | 2009-03-25 | 興和株式会社 | 血管壁選択的なａｃａｔ阻害剤 |
| US20060165605A1 (en) * | 2001-12-28 | 2006-07-27 | Ye-Mon Chen | Process to regenerate fcc spent catalyst |
| EP1566381B1 (en) | 2002-11-28 | 2009-11-11 | Kowa Co., Ltd. | Process for production of 1- 2-(benzimidazol-2-yl- thio)ethyl piperazine or salts thereof |
| AU2003300827B2 (en) * | 2002-12-05 | 2009-08-13 | Gilead Palo Alto, Inc. | Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| WO2004052861A1 (ja) * | 2002-12-12 | 2004-06-24 | Kowa Co., Ltd. | ヒドロキシアルキル環状ジアミン化合物 |
| MY140618A (en) * | 2003-02-28 | 2009-12-31 | Kowa Co | Method for preparing acid addition salts of polyacidic basic compounds |
| EP1631565A1 (en) * | 2003-05-07 | 2006-03-08 | Actelion Pharmaceuticals Ltd. | Piperazine-alkyl-ureido derivatives |
| JP4806566B2 (ja) * | 2003-05-28 | 2011-11-02 | 興和株式会社 | 環状ジアミン誘導体又はその塩の製造法 |
| MY140849A (en) * | 2003-07-07 | 2010-01-29 | Kowa Co | 2, 4-bis (trifluoroethoxy) pyridine compound and drug containing the compound |
| NZ544803A (en) * | 2003-08-29 | 2009-11-27 | Kowa Co | Method of stabilizing lipid-rich plaque and method of preventing rupture thereof |
| US7829552B2 (en) | 2003-11-19 | 2010-11-09 | Metabasis Therapeutics, Inc. | Phosphorus-containing thyromimetics |
| US7163944B2 (en) * | 2004-01-26 | 2007-01-16 | Kowa Co., Ltd. | Cyclic diamine compound and pharmaceutical containing the same |
| US7576203B2 (en) | 2004-06-30 | 2009-08-18 | Kowa Co., Ltd. | Method for producing cyclic diamine derivative |
| MX2007001890A (es) * | 2004-08-16 | 2009-02-12 | Procter & Gamble | Compuestos de fenol 2-(amino sustituido)-5, 6-sustituido, composiciones de teñido que las comprenden y su uso. |
| NZ555325A (en) | 2004-10-27 | 2009-07-31 | Daiichi Sankyo Co Ltd | Benzene compound having 2 or more substituents |
| TW200619204A (en) * | 2004-12-10 | 2006-06-16 | Kowa Co | Method for reduction, stabilization and prevention of rupture of lipid rich plaque |
| FR2920769B1 (fr) * | 2007-09-06 | 2009-10-30 | Galderma Res & Dev | Nouveaux derives de n-phenyl acetamide, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant |
| FR2920774B1 (fr) | 2007-09-06 | 2009-10-30 | Galderma Res & Dev | Nouveaux derives de n-phenul acatamide, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contentant |
| FR2920770B1 (fr) * | 2007-09-06 | 2009-10-30 | Galderma Res & Dev | Nouveaux derives de phenylurees, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant |
| JP5291979B2 (ja) | 2008-04-24 | 2013-09-18 | 株式会社フジクラ | 圧力センサ及びその製造方法と、該圧力センサを備えた電子部品 |
| US20120046364A1 (en) | 2009-02-10 | 2012-02-23 | Metabasis Therapeutics, Inc. | Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use |
| WO2011081117A1 (ja) | 2009-12-29 | 2011-07-07 | 興和株式会社 | 経口投与用固形医薬組成物 |
| CN102711763A (zh) * | 2009-12-29 | 2012-10-03 | 兴和株式会社 | 口服用医药组合物 |
| JP5800368B2 (ja) * | 2010-05-19 | 2015-10-28 | 興和株式会社 | 非アルコール性脂肪性肝炎の予防及び／又は治療剤 |
| CN105579457B (zh) * | 2013-03-20 | 2017-08-04 | 拜耳制药股份公司 | 取代的n‑联苯‑3‑乙酰基氨基‑苯甲酰胺和n‑[3‑(乙酰基氨基)苯基]‑联苯‑甲酰胺及其作为wnt信号通路抑制剂用途 |
| CN105693524A (zh) * | 2014-11-28 | 2016-06-22 | 浙江省化工研究院有限公司 | 一种硝基化合物的制备方法 |
| TW201825456A (zh) * | 2016-11-24 | 2018-07-16 | 日商帝人製藥股份有限公司 | 硫醚化合物的製造方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3629208A (en) * | 1969-06-18 | 1971-12-21 | Monsanto Co | N-aminoalkyl thiazolesulfenamides as vulcanization accelerators |
| CA2003283A1 (en) * | 1988-12-05 | 1990-06-05 | C. Anne Higley | Imidazoles for the treatment of atherosclerosis |
| WO1992007825A1 (en) * | 1990-11-05 | 1992-05-14 | Taisho Pharmaceutical Co., Ltd. | Phenol derivative |
| US5721266A (en) * | 1993-05-28 | 1998-02-24 | Warner-Lambert Company | Substituted imidazolinyl-imidazolines as antagonists of SH-2 binding and therapeutic uses thereof |
| US5596001A (en) * | 1993-10-25 | 1997-01-21 | Pfizer Inc. | 4-aryl-3-(heteroarylureido)quinoline derivatves |
| JP4191269B2 (ja) * | 1996-05-17 | 2008-12-03 | 興和株式会社 | 新規なアニリド化合物及びこれを含有する医薬 |
| AU6517698A (en) * | 1997-03-25 | 1998-10-20 | Kowa Company Ltd. | Novel anilide compounds and drugs containing the same |
| WO1999025712A1 (fr) * | 1997-11-14 | 1999-05-27 | Kowa Company, Ltd. | Nouveaux composes d'amide et medicaments contenant ces derniers |
-
1998
- 1998-05-26 EP EP98921809A patent/EP0987254B1/en not_active Expired - Lifetime
- 1998-05-26 KR KR1019997010894A patent/KR100549804B1/ko not_active IP Right Cessation
- 1998-05-26 DE DE69828276T patent/DE69828276T2/de not_active Expired - Lifetime
- 1998-05-26 CA CA002290744A patent/CA2290744C/en not_active Expired - Fee Related
- 1998-05-26 AT AT98921809T patent/ATE285402T1/de active
- 1998-05-26 HU HU0002294A patent/HUP0002294A3/hu unknown
- 1998-05-26 RU RU99128053/04A patent/RU2207341C2/ru not_active IP Right Cessation
- 1998-05-26 SK SK1582-99A patent/SK284891B6/sk not_active IP Right Cessation
- 1998-05-26 CZ CZ0415999A patent/CZ297451B6/cs not_active IP Right Cessation
- 1998-05-26 WO PCT/JP1998/002300 patent/WO1998054153A1/ja active IP Right Grant
- 1998-05-26 JP JP50047199A patent/JP3614865B2/ja not_active Expired - Fee Related
- 1998-05-26 ID IDW991669A patent/ID23377A/id unknown
- 1998-05-26 ES ES98921809T patent/ES2235328T3/es not_active Expired - Lifetime
- 1998-05-26 TW TW087108155A patent/TW589308B/zh not_active IP Right Cessation
- 1998-05-26 NZ NZ501156A patent/NZ501156A/en not_active IP Right Cessation
- 1998-05-26 PT PT98921809T patent/PT987254E/pt unknown
- 1998-05-26 AU AU74512/98A patent/AU728151B2/en not_active Ceased
- 1998-05-26 CN CN98805498A patent/CN1118457C/zh not_active Expired - Fee Related
-
1999
- 1999-11-25 NO NO19995783A patent/NO315045B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0987254A4 (en) | 2000-09-13 |
| CA2290744A1 (en) | 1998-12-03 |
| EP0987254B1 (en) | 2004-12-22 |
| CN1118457C (zh) | 2003-08-20 |
| DE69828276D1 (de) | 2005-01-27 |
| KR100549804B1 (ko) | 2006-02-08 |
| HUP0002294A3 (en) | 2001-10-29 |
| CN1258283A (zh) | 2000-06-28 |
| ES2235328T3 (es) | 2005-07-01 |
| PT987254E (pt) | 2005-04-29 |
| SK284891B6 (sk) | 2006-02-02 |
| HUP0002294A2 (hu) | 2001-09-28 |
| CZ297451B6 (cs) | 2006-12-13 |
| WO1998054153A1 (fr) | 1998-12-03 |
| CA2290744C (en) | 2009-12-22 |
| NO315045B1 (no) | 2003-06-30 |
| SK158299A3 (en) | 2001-02-12 |
| TW589308B (en) | 2004-06-01 |
| RU2207341C2 (ru) | 2003-06-27 |
| NO995783L (no) | 2000-01-26 |
| NO995783D0 (no) | 1999-11-25 |
| JP3614865B2 (ja) | 2005-01-26 |
| KR20010012926A (ko) | 2001-02-26 |
| AU728151B2 (en) | 2001-01-04 |
| DE69828276T2 (de) | 2005-12-15 |
| ATE285402T1 (de) | 2005-01-15 |
| CZ415999A3 (cs) | 2000-05-17 |
| EP0987254A1 (en) | 2000-03-22 |
| NZ501156A (en) | 2002-02-01 |
| AU7451298A (en) | 1998-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID23377A (id) | Senyawa-senyawa diamina siklik dan obat-obatan yang mengandung senyawa tersebut | |
| DE60232739D1 (de) | Aktivator des peroxisomproliferator-aktivierten rezeptors delta | |
| EP0287356A3 (en) | Novel compounds | |
| MY123337A (en) | Oxyiminoalkanoic acid derivatives. | |
| AU755654C (en) | Novel amide compounds and drugs containing the same | |
| DK0807627T3 (da) | Anilidforbindelser som ACAT-inhibitorer | |
| ATE372320T1 (de) | Cyclische amidderivate | |
| EP1306369A4 (en) | NEW SULFUR COMPOUNDS AND INTERMOLECULAR COMPOUNDS CONTAINING THEM AS A COMPONENT | |
| ATE502005T1 (de) | Amphotere lipidverbindung und deren verwendung | |
| DE69004598D1 (de) | 6-Amino-6-desoxyfumagillole, ihre Herstellung und ihre Verwendung. | |
| FI913067A (fi) | Bisfosfonsyraderivat, deras framstaellning och anvaendning. | |
| EP1020451A4 (en) | NEW ANILIDE COMPOUNDS AND DRUGS CONTAINING THEM | |
| HU9400246D0 (en) | Modified oligodeoxyribonucleotides, process for producing them, and pharmaceutical compositions containing them | |
| DE69319859T2 (de) | Neue tetracyclische verbindungen | |
| IL136510A0 (en) | Acylated hetero-alicyclic derivatives and pharmaceutical compositions containing the same | |
| ATE133677T1 (de) | Bisphosphonsäurederivate, ihre produktion und ihre verwendung | |
| TH13398EX (th) | เภสัชภัณฑ์ |